A $6.3 billion cryptocurrency heist on Binance has triggered a sharp flight to quality, driving global bond yields to their largest monthly declines in months. As equity markets falter amid tech-sector volatility, investors are aggressively pivoting toward the perceived security of U.S. Treasurys and German Bunds.
American International Group is set to acquire Everest Compañía de Seguros Generales Chile, marking a strategic expansion into the Andean insurance market. The agreement encompasses the entirety of the firm's licensed operations, its professional workforce, and a diverse existing portfolio focused on corporate and upper-middle-income clients.
With Xerox shares plummeting 36% year-to-date, Prague-based investor Starteepo Sicav has issued an ultimatum: the board must now consider selling the entire company. The activist fund, which holds a 7.34% stake, argues that only a radical strategic review can reverse the erosion of shareholder value following dismal third-quarter results.
An 8% drop in Iradimed shares on Friday signaled investor unease as the medical device manufacturer tightened its full-year revenue and earnings targets. Trading at $79.17, the stock hit its lowest point since October 2025, deepening a year-to-date decline that now stands at 19%.
Walmart is moving into the home energy sector through a strategic investment in Base Power, a Texas-based firm specializing in residential battery systems. The partnership aims to lower utility costs for consumers while providing a reliable backup solution for those facing the volatility of the Texas electrical grid.
A loss of 10.8 billion Mexican pesos for the third quarter marks a significant recovery for Petroleos Mexicanos, which reported a 61.24 billion peso deficit during the same period last year. The state-owned oil giant credits the improved bottom line to a robust increase in fuel marketing and domestic demand.
Building a new refinery costs double what ExxonMobil spends to overhaul its existing infrastructure, prompting CEO Darren Woods to double down on high-margin production sites in Texas and Louisiana. By focusing capital on legacy assets, the oil major aims to squeeze more value from its established chemical and petroleum portfolios.
Zions Bancorporation will spend up to $72 million on stock repurchases during the final quarter of the year, according to a recent board authorization. This move marks the latest step in a broader capital return strategy aimed at reaching a total of $300 million in buybacks throughout 2024.
A 12% drop in stock price greeted Sensient Technologies on Friday, even as the food color and flavor manufacturer outperformed profit expectations for the third quarter. Investors reacted sharply to a revenue shortfall, sending shares down to $116.47, effectively tempering the company's 24% gain recorded earlier this year.
San Diego biotech firm Aspen Neuroscience saw its stock retreat during Friday’s initial trading session, slipping 16% to $12.66 by midday. The slide follows an IPO that priced shares at $15, landing at the bottom of the company’s projected $15 to $17 range as investor enthusiasm cooled immediately upon opening.
A vessel attacked by explosives in the Strait of Hormuz has sent global energy markets into a frenzy, pushing crude and refined product futures sharply upward. The incident highlights the fragility of critical shipping lanes as regional security threats overshadow ongoing diplomatic efforts to stabilize the volatile energy sector.
Investors cooled on Bambusa Therapeutics during the company's first day of public trading Friday, pushing shares down more than 9% following an upsized initial public offering. The Boston-based biopharmaceutical firm, which develops clinical-stage treatments, struggled to maintain momentum despite exceeding its initial target for share volume.
Investors pushed Piper Sandler shares down 7.4% on Friday after the Minneapolis-based investment bank reported third-quarter results that failed to meet analyst expectations. The company saw both earnings and revenue contract compared to the same period last year, signaling a difficult quarter for the firm's bottom line.
Investors reacted sharply on Friday as Agios Pharmaceuticals confirmed a three-month delay in the regulatory review for its sickle cell disease treatment. The decision by the Food and Drug Administration pushes the new target date for the oral drug, mitapivat, to February 1, disrupting the company's anticipated approval timeline.
A 28% collapse in share price hit Arbor Realty Trust on Friday, as the mortgage real estate investment trust pivoted to capital preservation. The company reported an $85.4 million quarterly loss, forcing an immediate suspension of dividends to address a mounting debt load of $10.75 billion.
A cryptic message on the Ascend.io website confirms the company is winding down operations, marking the final chapter for the data-management startup. Behind the shuttered service lies a quiet acquisition by Apple, finalized in June, according to regulatory filings recently disclosed by the European Commission.
A 15 percent stock plunge greeted TFI International investors Friday morning as the Canadian logistics giant posted quarterly profits that trailed analyst expectations. While revenues climbed across several key segments, a sharp contraction in less-than-truckload operating income and a conservative fourth-quarter outlook triggered a swift market sell-off.
A 0.9% rise in third-quarter gross domestic product marks two consecutive periods of expansion for the Mexican economy. Bolstered by robust domestic demand and a surge in exports linked to the artificial intelligence boom, the country continues to outperform expectations despite a slight cooling from the second quarter's rapid pace.
A 36% jump in third-quarter revenue to $5.12 billion propelled Regeneron Pharmaceuticals well beyond analyst expectations of $4.56 billion. The surge, driven by record performance across three core therapies, sent the company’s stock price climbing 13% to reach $924.17 by the end of the trading session.
A brutal selloff swept through the semiconductor sector on Friday, erasing over $120 billion in market value from Intel alone. The slump, triggered by Intel’s bleak fourth-quarter guidance and a cooling market for personal computers, rapidly deepened concerns over the sustainability of massive capital expenditures in artificial intelligence infrastructure.
Imperial Oil posted a robust third-quarter net income of 2.45 billion Canadian dollars, a significant jump from 539 million dollars a year prior. While refinery throughput and production volumes dipped due to maintenance and pipeline disruptions, surging bitumen prices and favorable refining margins propelled the company past analyst expectations.
With Craig Conti departing the Mesa-based smart mobility firm to pursue opportunities in a different industry, Verra Mobility has tapped Alvarez & Marsal managing director Matthew Kvarda to bridge the leadership gap. Kvarda assumes the role of interim chief financial officer on November 5, immediately following Conti’s exit.
Acumen Pharmaceuticals saw its market valuation evaporate on Friday, with shares plummeting nearly 86% to hit a record low of 30 cents. The collapse followed the company's abrupt decision to scrap its lead drug candidate, sabirnetug, after the treatment failed to meet primary efficacy goals in a Phase 2 Alzheimer's trial.
Nigeria-focused financial services platform OPay has priced its initial public offering at $19 per share, landing at the bottom of its projected $19 to $21 range. The company successfully raised $304 million through the sale of 16 million American depositary shares as it prepares for its market debut.
A staggering $120 billion evaporated from Intel’s market value Friday, dragging the broader semiconductor sector into a sharp decline. Investors are retreating from chipmakers and Big Tech alike, rattled by cooling personal-computer demand and mounting skepticism over the immediate financial returns from massive artificial intelligence infrastructure spending.
Bolstered by higher approved rate plans across its utility subsidiaries, Chicago-based Exelon has lifted its full-year profit outlook. The company now projects adjusted earnings per share between $2.85 and $2.91, raising the lower end of its previous guidance as it navigates rising operational costs and severe weather demands.
Global automobile production dipped 2% during the third quarter, yet Lear Corporation managed to outpace the industry slump. The autoparts manufacturer reported a profit of $136.6 million for the period ending Oct. 3, bolstered by a steady stream of new business awards that helped offset shrinking manufacturing volumes worldwide.
A sharp 5% decline in new vehicle retail sales pushed AutoNation’s third-quarter profit down to $162.3 million, a notable retreat from the $215.1 million reported during the same period last year. Despite the softening demand, the retailer outperformed Wall Street expectations, bolstered by a fresh $1 billion stock buyback authorization.
Dominion Energy outperformed market expectations in the third quarter, reporting $1.16 billion in profit as top-line growth eclipsed rising operational costs. The utility provider’s adjusted earnings of $1.28 per share surpassed the $1.21 consensus forecast, signaling resilience despite a substantial climb in expenses across its service portfolio.
After a tenure defined by federal fiscal policy and international finance, former Finance Minister Bill Morneau will step into the role of board chair at Canadian Imperial Bank of Commerce. He replaces Katharine Stevenson, who concludes her decade-long service with the institution at the end of this year.
